Intuitive Surgical Inc
ISRG508.130USD
+20.199+4.14%
Close 04/24, 16:00（ET）Quotes delayed by 15 min
182.11BMarket Cap
78.41P/E TTM
More Details of Intuitive Surgical Inc Company
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Company Info
Company codeISRG
Company nameIntuitive Surgical Inc
IPO dateJun 13, 2000
Founded at1995
CEODr. Gary S. Guthart, Ph.D.
Number of employees15638
Security typeOrdinary Share
Fiscal year-endJun 13
Address1020 Kifer Road
CitySUNNYVALE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94086
Phone14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
Company codeISRG
IPO dateJun 13, 2000
Founded at1995
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
2.04K
-54.69%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
1.61K
--
Dr. Amy L. Ladd, M.D.
Dr. Amy L. Ladd, M.D.
Independent Director
Independent Director
671.00
-18.27%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
240.00
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
By RegionUSD
Name
Revenue
Proportion
U.S.
5.59B
66.92%
Outside of United states
2.76B
33.08%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Shareholder
Update time: Fri, Feb 21
Update time: Fri, Feb 21
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.94%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.89%
Fidelity Management & Research Company LLC
2.93%
Other
74.78%
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.94%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.89%
Fidelity Management & Research Company LLC
2.93%
Other
74.78%
Type
Shareholder
Proportion
Investment Advisor
43.07%
Investment Advisor/Hedge Fund
35.63%
Bank and Trust
2.46%
Research Firm
2.40%
Pension Fund
2.20%
Hedge Fund
1.77%
Sovereign Wealth Fund
1.39%
Individual Investor
0.50%
Family Office
0.15%
Other
10.43%
Institutional Shareholding
Update time: Sun, Jan 19
Update time: Sun, Jan 19
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
3382
322.69M
90.06%
-610.71K
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
2023Q2
2932
311.78M
88.97%
-2.17M
2023Q1
2848
309.16M
88.25%
-6.75M
2022Q4
2840
310.11M
87.74%
-7.77M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
32.06M
8.95%
+364.96K
+1.15%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
18.57M
5.18%
+488.70K
+2.70%
Dec 31, 2024
State Street Global Advisors (US)
15.31M
4.27%
+255.30K
+1.70%
Dec 31, 2024
T. Rowe Price Associates, Inc.
13.96M
3.9%
-133.51K
-0.95%
Dec 31, 2024
Fidelity Management & Research Company LLC
10.49M
2.93%
-117.40K
-1.11%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.76M
2.17%
+243.80K
+3.25%
Dec 31, 2024
Capital World Investors
7.43M
2.07%
+11.93K
+0.16%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
7.37M
2.06%
+98.84K
+1.36%
Feb 28, 2025
JP Morgan Asset Management
7.22M
2.01%
+123.15K
+1.74%
Dec 31, 2024
Fisher Investments
4.87M
1.36%
+86.49K
+1.81%
Dec 31, 2024
View more
Related ETFs
Update time: Sat, Apr 5
Update time: Sat, Apr 5
Name
Proportion
Langar Global HealthTech ETF
19.52%
iShares U.S. Medical Devices ETF
13.37%
First Trust Nasdaq Lux Digi Health Solutions ETF
8.9%
Global X Robotics & Artificial Intelligence ETF
7.07%
Invesco AI and Next Gen Software ETF
7.04%
Goldman Sachs Future Health Care Equity ETF
6.3%
Neuberger Berman Disrupters ETF
6.01%
Franklin Intelligent Machines ETF
5.81%
iShares Health Innovation Active ETF
5.34%
Simplify Health Care ETF
4.99%
View more
Langar Global HealthTech ETF
Proportion19.52%
iShares U.S. Medical Devices ETF
Proportion13.37%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion8.9%
Global X Robotics & Artificial Intelligence ETF
Proportion7.07%
Invesco AI and Next Gen Software ETF
Proportion7.04%
Goldman Sachs Future Health Care Equity ETF
Proportion6.3%
Neuberger Berman Disrupters ETF
Proportion6.01%
Franklin Intelligent Machines ETF
Proportion5.81%
iShares Health Innovation Active ETF
Proportion5.34%
Simplify Health Care ETF
Proportion4.99%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 05, 2021
Split
1>3
Date
Type
Ratio
Aug 05, 2021
Split
1>3